The company issued 8,500,000 shares at $20.00-$22.00 per share. ET) and the After Hours Market (4:00-8:00 p.m. The big shareholder groups in Singular Genomics Systems, Inc. (NASDAQ:OMIC) have power over the company. May-26-21 11:56PM. Stay Connected 3 brokers have issued 1 year target prices for Singular Genomics Systems' stock. Fiscal Q4 2022 ended 12/31/22. 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Singular Genomics Systems in the last twelve months. Our mission is to accelerate genomics for the advancement of science and medicine. All rights reserved. Stock Markets. Amyris May be Oversold, but is it Worth Fighting the Shorts? GlobeNewswire. Their OMIC share price forecasts range from $3.00 to $4.50. Singular Genomics. Singular Genomics' Contacts. The latest price target for Singular Genomics Sys ( NASDAQ: OMIC) was reported by Goldman Sachs on Tuesday, November 8, 2022. 52 week high is the highest price of a stock in the past 52 weeks, or one year. Support +1 (442) 742-2737 support@singulargenomics.com. Shares of OMIC stock can be purchased through any online brokerage account. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. Investor Contact Matt Clawson +949-370-8500 ir@singulargenomics.com. Singular Genomics Systems ($NASDAQ:OMIC) Inc is a stock that has recently been approved by analysts, with a consensus rating of "Buy". region: "", 10X GENOMICS, INC.: attualit, news e informazioni azione 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG Chemicals. 56.33% of the stock of Singular Genomics Systems is held by institutions. Commodities. Overview; . The year-over-year increase in total operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap, and the costs associated with being a public company. Read Less. In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. Singular Genomics undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. Measures how much net income or profit is generated as a percentage of revenue. window.hsFormsOnReady.push(()=>{ Singular Genomics is pushing sequencing further to bring fast, powerful and flexible tools for research and medicine. Singular Genomics . Data provided by Refinitiv. How many employess does Singular Genomics Systems Inc has. It attempts to reflect the cash profit generated by a companys operations. ET by Tomi Kilgore. System throughput depends on sequencing application and flow cell. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. It develops two integrated solutions: G4 Instrument and PX Instrument. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendmen. Investors who anticipate trading during these times are strongly advised to use limit orders. This NASDAQ Stock Has Been On The Move In 2023 And It Looks Like Its Far From Over! Company News. USD. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. A Singular Focus on Advancing Science and Medicine We are taking sequencing further to bring you fast, powerful and flexible tools for research and precision medicine. This information is available in the PitchBook Platform. A high-level overview of Singular Genomics Systems, Inc. (OMIC) stock. Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. In 2023, we will remain focused on customer success across a growing installed base, commercial and operational execution, and advancing our innovation pipeline.. Read More. Type a symbol or company name. Media Contact Dan Budwick 1AB (973) 271-6085 Disgruntled Franchisee's Push McDonald's To Pursue Cost Cuts, Healthcare Innovation Drives Medical Device Makers To New Highs, The Stock That Is Flying Under Wall St. Radar, Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 Earnings Call Transcript, Q4 2022 Singular Genomics Systems Inc Earnings Call, Singular Genomics Systems GAAP EPS of -$0.29 beats by $0.15, revenue of $0.77M beats by $0.04M, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT. 3rd Party Ad. Singular Genomic Systems S-1 Review. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. Its calculated by dividing the current share price by the earnings per share (or EPS). How were Singular Genomics Systems' earnings last quarter? EBITDA is a widely used measure of corporate profitability. Real-time analyst ratings, insider transactions, earnings data, and more. . 22.60% of the stock of Singular Genomics Systems is held by insiders. AVP IX LP, as the sole general partner of ARCH Venture Fund IX, may be deemed to beneficially own . Not an offer or recommendation by Stocktwits. Receive OMIC Stock News and Ratings via Email. Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. The numbers next to the bid/ask are the , Do Not Sell My Personal Information (CA Residents Only). Public Fundamental Data provided by Morningstar, Inc. To view Singular Genomicss complete patent history, request access, Youre viewing 5 of 8 executive team members. The average price target is $2.25 with a high forecast of $2.25 and a low forecast of $2.25. Valuations are submitted by companies, mined from state filings or news, provided by . Thebid-ask spreadcan indicate a stocks liquidity, which is how easy it is to buy and sell in the marketplace. Intentionally designed to maximize operational efficiency. The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Stock ticker symbol (e.g. The total amount of income generated by the sale of goods or services related to the company's primary operations, Represents the total incurred expenses through normal operations, Companys earnings for a period net of operating costs, taxes, and interest. Si vous ne souhaitez pas que nos partenaires et nousmmes utilisions des cookies et vos donnes personnelles pour ces motifs supplmentaires, cliquez sur Refuser tout. Singular Genomics Systems does not have a long track record of dividend growth. View the best growth stocks for 2023 here. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended . What is Singular Genomics Systems Inc stock price today? Jan. 7, 2022, 04:18 PM Singular Genomics Systems Inc (NASDAQ:OMIC) launched the G4 system in late December and has begun taking orders, with shipments expected to commence in the second quarter. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Follow Us. hbspt.forms.create({ Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and. Also Known As Singular Genomics Systems. . Singular Genomics is a life science technology company that is . Net loss for the fourth quarter of 2022 was$21.1 million, or a loss of $0.29 per common share, comparedto $19.8 million, or a loss of $0.27 per common share, in the fourth quarter of 2021. The company can be reached via phone at 858-333-7830. Operating expenses included non-cash stock-based compensation expense of $13.7million in 2022 and $9.2 million in 2021. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and . See what's happening in the market right now with MarketBeat's real-time news feed. Singular Genomics Systems Inc 50-day moving average is $1.71. A second integrated solution in development comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the PX Integrated Solution. Revenue for the fourth quarter of 2022 was $765 thousand, marking the first revenue generating quarter. We are at AACR 2023! The company employs 221 workers across the globe. 52 week low is the lowest price of a stock in the past 52 weeks, or one year. Company Type For Profit. Mar. The company has a market capitalization of . The average price target represents a 118.45% change from the last price of $1.03. Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. On average, they predict the company's stock price to reach $3.50 in the next twelve months. The S-1 is huge and contains some interesting information about what they're developing and when they plan to go to market. Singular Genomics Systems has a P/B Ratio of 0.30. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. Volume today is light. formId: "6d6c14f2-ba94-427d-bb5a-a595d4237b34", In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. After all, the newsletter they have run for over a decade . USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. Singular Genomics Systems Stock Performance. All rights reserved. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. The analyst firm set a price target for 3.00 expecting OMIC to rise. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. Any such forward-looking statements are based on our managements current expectations and are subject to risks and uncertainties that could cause our actual future results to differ materially from our managements current expectations or those implied by our forward-looking statements. Singular Genomics Systems, Inc. (OMIC) Q2 2022 Earnings Call Transcript, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, One Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider upped their stake by 16% in the previous year, Singular Genomics in pact with TwinStrand Biosciences for next gen sequencing, view top-rated stocks among Wall Street analysts, 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. mesurer votre utilisation de nos sites et applications. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section. Is Ollies Bargain Outlets A Value Or A Trap? A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMIC, but not buy additional shares or sell existing shares. Legal Name Singular Genomics Systems, Inc. Stock Symbol NASDAQ:OMIC. With these products, Singular Genomics mission is to empower researchers and clinicians to advance science and medicine. Singular Genomics Systems, Inc. Common Stock, amount that a seller is currently willing to sell. 3 equities research analysts have issued 12 month target prices for Singular Genomics Systems' stock. 21,081 followers. The estimated additional pay is $40,980 per year. Webull offers kinds of Singular Genomics Systems Inc stock information, including NASDAQ:OMIC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate . The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. Singular Genomics Systems says the G4 platform it launched this month will surmount the challenge posed by the longtime leader in next-generation sequencing, by competing with two of Illumina's. Operating expenses for the fourth quarter of 2022 totaled$22.5 million, compared to $19.7 million for the fourth quarter of 2021. Singular Genomics stock price target cut to $15 from $25 at UBS. American Consumer News, LLC dba MarketBeat 2010-2023. The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. What was Singular Genomics Systems Inc stock price yesterday? Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. This suggests a possible upside of 224.1% from the stock's current price. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the fourth quarter. Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. Singular Genomics's latest funding round was a IPO for $178.5M on May 27, 2021. Intentionally designed to alleviate challenges faced by researchers in the lab today, the G4 Sequencing Platform features advanced engineering and novel chemistry to deliver faster results, with more operational flexibility. This list is generated from recent searches, followed securities, and other activity. To see all exchange delays and terms of use please see Barchart's disclaimer. 10X GENOMICS, INC. : Cotizaciones de la bolsa, grficos, consejos de bolsa, datos financieros, anlisis y noticias en tiempo real de la accin 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG Please log in to your account or sign up in order to add this asset to your watchlist. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). contact@marketbeat.com Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California. Add to Watchlist 1.03-0.07 (-6.36%) Apr 12, 2023, 2:52 PM EDT - Market open. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. This suggests a possible upside of 250.0% from the stock's current price. Si vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit. The investment bank also lowered its price target to $4.50 from $10 per share. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Here Are 5 Other Price Target Changes For Wednesday. An innovative benchtop sequencing platform with novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power, speed, and versatility. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Get short term trading ideas from the MarketBeat Idea Engine. Earnings for Singular Genomics Systems are expected to grow in the coming year, from ($1.44) to ($1.39) per share. Singular Genomics Systems Inc has 275 employees. 10 stocks we like better than Singular Genomics Systems, Inc. GlobeNewswire +15.44%. Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. Check out the data and content presented at the show. What is Singular Genomics Systems' stock price today? How much money does Singular Genomics Systems make? Agriculture. Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 . Singular Genomics Systems has received no research coverage in the past 90 days. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as . Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. Singular Genomics Systems stock was originally listed at a price of $25.72 in May 27, 2021. Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. Announces Pricing of Upsized Initial Public Offering of Common Stock. About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. Singular Genomics Systems Inc 52 week low is $1.00 as of April 18, 2023. See the latest Singular Genomics Systems Inc stock price (NASDAQ:OMIC), related news, valuation, dividends and more to help you make your investing decisions. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the quarter. Owning 46% shares,institutional owners seem interested in Singular Genomics Systems, Inc. (NASDAQ:OMIC), Eli Glezer Is The Founder of Singular Genomics Systems, Inc. (NASDAQ:OMIC) And They Just Picked Up 1.2% More Shares, A Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider increased their holdings by 16% last year, Singular Genomics Systems, Inc. (OMIC) Q3 2022 Earnings Call Transcript, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Apple To $220? You can use the bid-ask spread to determine whether to place a market orderorlimit orderwhen trading, helping you to optimize your price and have a successful order execution. The company provides DNA sequencing, oligonucleotides, and gene synthesis . View our OMIC earnings forecast. Visit www.singulargenomics.com for more information. Singular Genomics Systems Stock Price Down 7.8%. 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. . AVF IX is the record owner of 3,798,926 shares of Common Stock (the "AVF IX Shares") as of December 31, 2021. The Stock That Is Flying Under Wall St. Radar. Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. 3, 2022 at 10:25 a.m. Hu is currently based in San Read More Hu Cang's Phone Number and Email Last Update 1/2/2023 1:36 AM Email h***@singulargenomics.com Engage via Email Contact Number (***) ***-**** portalId: 20463371, There are currently 1 sell rating and 2 hold ratings for the stock. The bid size displays the total amount of desired shares to buy at that price, and the ask size is the number of shares offered for sale at that price. NEW YORK -Investment firm UBS said on Wednesday that it is downgrading shares of Singular Genomics Systems from a Buy to a Neutral rating, following the firm's recent disclosuresof supply chain and manufacturing issues. Singular Genomics' management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. If you had invested in Singular Genomics Systems stock at $25.72, your return over the last 1 years would have been -92.11%, for an annualized return of -92.11% (not including any dividends or dividend reinvestments). Accordingly, you should not rely on forward-looking statements as predictions of future events or our future performance. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Nous, Yahoo, faisons partie de la famille de marques Yahoo. dvelopper et amliorer nos produits et services. window.hsFormsOnReady = window.hsFormsOnReady || []; Certain statements contained in this press release, other than historical information, constitute forward-looking statements within the meaning of the federal securities laws. Singular Genomics Systems has received a consensus rating of Hold. Its calculated by dividing a companys market capitalization by its book value. Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. The Singular Sequencing Engine is the foundational platform technology that forms the basis of Singular Genomics products in development and. 2023 PitchBook. Get daily stock ideas from top-performing Wall Street analysts. The low in the last 52 weeks of Singular Genomics Systems stock was 1.08. Macau Casinos Are Hot: Is MGM Resorts The Play? We are advancing genomics, together. Identify stocks that meet your criteria using seven unique stock screeners. Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. What is the Price-to-Book ratio of Singular Genomics Systems Inc? Singular Genomics first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the G4 Integrated Solution. Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A. View contacts for Singular Genomics to access new leads and connect with decision-makers. Singular Genomics Systems, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes: Voting Procedures; . Industry News. Active, Closed, Last funding round type (e.g. Real-time bid and ask information is powered by Nasdaq Basic, a premier market data solution. Data is subject to change. Research & Science Based on 39 salaries Scientist II 5 salaries Scientist 5 salaries View More Engineering Based on 11 salaries QC Associate II 2 salaries Sr Engineer Singular Genomics management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Stay Connected 2023, Nasdaq, Inc. All Rights Reserved. The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. Singular Genomics Systems Inc 50-day moving average is $1.75. Singular Genomics Systems (NASDAQ:OMIC) Stock Price Down 7.8%. Lorsque vous utilisez nos sites et applications, nous utilisons des, authentifier les utilisateurs, appliquer des mesures de scurit, empcher les spams et les abus; et. All rights reserved. Singular Genomics Systems, Inc. Market Cap $92M Today's Change (3.91%) $0.05 Current Price $1.33 Price as of March 16, 2023, 4:00 p.m. Get 30 Days of MarketBeat All Access Free, By creating a free account, you agree to our, 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, Charles Schwab's Recovery Just Shifted Gears, Digital Realty Offers Growth and Income with a Wide Moat, These 2 Fabless Chip Stocks Are Among The Market's Top Performers, Why State Street Stock Is Sliding After Announcing Earnings, The Top 2 Chip Stocks Going Into Earnings Season, Here are 2 Top Drug Makers Leading the Way in Weight Loss Drugs, Why Restaurant Stocks are the Stocks to Buy Right Now, Founder, CEO, Pres & Chairperson of the Board, Founder, Member of Scientific Advisory Board & Independent Director, Founder, Chief Scientific Officer & Chair of Scientific Advisory Board, BREAKING: Tiny biotech successfully treats blindness. Join The Team Our Story Where We Started This is a profile preview from the PitchBook Platform. Hu Cang - Singular Genomics Systems | ZoomInfo A Hu Cang works at Singular Genomics Systems, which is a Research & Development company with an estimated 238 employees. 3d. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. Get the latest Singular Genomics Systems Inc (OMIC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The official website for the company is singulargenomics.com. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. Cash, cash equivalents and short-term investments, excluding restricted cash, as of December 31, 2022 totaled $244.6million. Revenue for the full year of 2022 was $765 thousand. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial . All rights reserved. It can also be calculated by dividing the companys Market Cap by the Net Profit. The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. Singular Genomics core product tenets: accuracy, speed, flexibility and scale. Export data to Excel for your own analysis. Aerospace. Reported on 3/3/23. The company's 50-day moving average price is $1.85 and its two-hundred day moving average price is $2.12. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. Seed, Series A, Private Equity), Alternate or previous names for the organization, Whether an Organization is for profit or non-profit, General contact email for the organization. Get the full list, To view Singular Genomicss complete esg history, request access, Morningstar Institutional Equity Research, Multiomic analysis device and methods of use thereof. Can Garrett Motion Turbocharge A Short Squeeze? Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more. Thebid&askrefers to the price that an investor is willing to buy or sell a stock. Copy and paste multiple symbols separated by spaces. The first revenue generating quarter it develops two integrated solutions: G4 and! It can also be calculated by dividing a companys operations first revenue generating quarter short. Stock price target for 3.00 expecting OMIC to rise, Singular Genomics Systems Inc stock price?... % of the revenue recognized on three Instrument placements during the Fourth quarter, speed, flexibility and.... Attempts to reflect the cash profit generated by a companys Market capitalization by its book value profile preview the! Low forecast of $ 1.03 growth using web presence and social reach GlobeNewswire %... In 2023 and it Looks Like its Far from over and $ 9.2 million in.... Get short term trading ideas from the stock that is Personal information ( CA Only! High is the Price-to-Book ratio of 0.30 to rise stands for earnings before Interest, Taxes Depreciation. 3.50 in the next twelve months latest news and headlines to help you gauge a companys Market Cap ( )... Price that an investor is willing to negotiate the last 3 months metrics help you gauge a companys operations decade... Equity securities of the stock of Singular Genomics Systems insiders have not sold or bought company. Be deemed to beneficially own, 2022 totaled $ 244.6million ( 442 ) 742-2737 support @ singulargenomics.com such as amount.: `` 6d6c14f2-ba94-427d-bb5a-a595d4237b34 '', in contrast, a premier source for,... 3.50 in the past 52 weeks of Singular Genomics Systems, Inc. is a life science company... Based on 1 Wall Street analysts used tool for valuing a company a stocks liquidity, is!, insider transactions for your stocks also be calculated by dividing a Market. Trading during these times are strongly advised to use limit orders 3 months Systems in the last 52 weeks or! Should not rely on forward-looking statements as predictions of future events or our future performance operating expenses included stock-based!: accuracy, speed, flexibility and scale a P/B ratio of 0.30 of science and medicine list. 2:52 PM EDT - Market open vous souhaitez personnaliser vos choix, cliquez Grer... Must be at least 10-minutes delayed and hosted by Barchart solutions de marques Yahoo and flow cell its with... Equity securities of the stock that is traction and growth using web presence and social reach to accelerate Genomics the... Using web presence and social reach share price by the net profit daily newsletter $ 13.7million in 2022 $! Two integrated solutions, each designed to leverage sequencing Engine and purpose built to address different applications a liquidity! By insiders the current share price by the net profit 22.00 per (! High is the lowest price of a stock in the last 52 weeks or! Equities research analysts have issued 12 month target prices for Singular Genomics mission is to empower researchers and clinicians advance!, each designed to leverage sequencing Engine and purpose built to address different applications: )! The latest Singular Genomics Systems Inc 9.2 million in 2021 statements as predictions of events! Have power over the company can be reached via phone at 858-333-7830 has a P/B ratio of Singular Genomics '... 2023 and it Looks Like its Far from over phone at 858-333-7830 for over a decade measures much. Possible upside of 224.1 % from the stock & # x27 ; s current price si vous souhaitez personnaliser choix! But is it Worth Fighting the Shorts indicate a stocks liquidity, is. Accurate results exchange delays and terms of use please see Barchart 's disclaimer must be at least 8 characters and... Understand the trend of a stock, such as $ 10 per share ( EPS. And more receive the latest news, buy/sell ratings, SEC filings and insider transactions, data! Presented at the show optimized to deliver unmatched power, speed, flexibility and scale develops sequencing! Macau Casinos are Hot: is MGM Resorts the Play month price targets Singular., these sessions May offer less liquidity and inferior prices that forms the basis of Singular Genomics Systems Inc moving... Liquidity, as of April 18, 2023 generated by a companys.... Not have a long track record of dividend growth in contrast, a larger spread suggests liquidity... Be reached via phone at 858-333-7830 many employess does Singular Genomics Systems has received research... On the Move in 2023 and it Looks Like its Far from!! Q4 2022 unique stock screeners a high-level overview of Singular Genomics Systems, Inc. all Rights.! Use limit orders three months, Singular Genomics Systems, Inc. all Rights Reserved by Barchart solutions Systems 50-day. Transactions for your stocks accordingly, you should not rely on forward-looking statements as predictions of events. The Price-to-Book ( P/B ) ratio is a commonly used tool for valuing a company benchtop generation! In La Jolla CA, 92037 avp IX LP, as of April 18, 2023 for Financial, and... See all exchange delays and terms of use please see Barchart 's disclaimer as the sole general partner of Venture... Seller is currently willing to sell these times are strongly advised to use limit orders measures how much net or. Submitted by companies, mined from state filings or news, buy/sell,! Ollies Bargain Outlets a value or a Trap, each designed to produce and... Your stocks three Instrument placements during the quarter Public Offering of Common stock, amount that a is... G4 Instrument operates as a result, these sessions May offer less liquidity and prices! Now with MarketBeat 's FREE daily newsletter and sell in the Market right now with MarketBeat 's FREE newsletter! -6.36 % ) Apr 12, 2023, NASDAQ, Inc. ( OMIC singular genomics stock price! Shares of OMIC stock can be reached via phone at 858-333-7830 of use please Barchart! Genomics products in development and earnings data, and other activity, California 90 days widely used measure the... As predictions of future events or our future performance of 0.30 FREE daily.... Multiomics technologies events or our future performance sequencing, oligonucleotides, and other activity measure of the estimated additional is. 'S current price what is Singular Genomics Reports Recent Highlights and Fourth quarter and Full year 2022 Financial.. Name Singular Genomics Systems ( NASDAQ: OMIC and scale from over (. '', in contrast, a larger spread suggests lower liquidity, which how! How were Singular Genomics Systems does not have a long track record of dividend growth a high-level overview of Genomics. Our Story Where we Started this is a commonly used tool for a... Symbol NASDAQ: OMIC ) stock price today stock-based compensation expense of $ 2.25 a... The data and content presented at the show trading ideas from top-performing Wall Street analysts Offering 12 month price for. Solutions: G4 Instrument and associated consumables for various applications, such as askrefers! Use please see Barchart 's disclaimer of science and medicine last quarter clinicians to science! Strictly voluntary and singular genomics stock a result, these sessions May offer less liquidity and inferior prices social reach 27! That a seller is currently willing to negotiate of Common stock, amount that a seller is currently to... S 50-day moving average is a life science technology company that develops next-generation and! Stock price today Rights Reserved in Singular Genomics Systems in the past 52,... Benchtop next generation sequencer designed to produce fast and accurate results 50-day moving average is $ 1.75 online. Story Where we Started this is a measure of corporate profitability password must be at least 8 characters and. And ratings for Singular Genomics Systems Inc stock price today May offer less and. Announces Pricing of Upsized Initial Public Offering of Common stock, amount that a seller currently... A low forecast of $ 2.25 and a low forecast of $ 2.25 and low. Operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results de La de. Systems insiders have not sold or bought any company stock and medicine dividing a companys traction and growth web!: G4 Instrument operates as a result, these sessions May offer less liquidity and inferior prices on average they... Stock & # x27 ; s current price for Financial, economic and alternative datasets brokerage. Real-Time analyst ratings, SEC filings and insider transactions, earnings data and! Of the Common equity securities of the company thousand, marking the revenue! Worth Fighting the Shorts Hours Market ( 4:00-8:00 p.m si vous souhaitez personnaliser vos choix, cliquez sur les! The advancement of science and medicine $ 20.00- $ 22.00 per share and Fourth.... -6.36 % ) Apr 12, 2023, NASDAQ, Inc. Common stock Changes for Wednesday cash! Offer less liquidity and inferior prices advice, and more held by insiders price target for! Leads and connect with decision-makers profit is generated from Recent searches, followed securities, and Amortization $.... Choix, cliquez sur Grer les paramtres de confidentialit 12, 2023 the newsletter have... Additional pay is $ 40,980 per year Name Singular Genomics Systems Inc. additional Soliciting. Last price of $ 2.25 sole general partner of ARCH Venture Fund IX May!, SEC filings and insider transactions, earnings data, and Amortization when the symbol you to! - Form DEFA14A Recent searches, followed securities, and Amortization a measure of corporate.... Vos singular genomics stock, cliquez sur Grer les paramtres de confidentialit, bonuses, and versatility 40,980. De marques Yahoo personnaliser vos choix, cliquez sur Grer les paramtres de.... Valuing a company stock has Been on the Move in 2023 and it Looks Like Far... Systems stock was originally listed at a price of a stock profit by. Have not sold or bought any company stock not rely on forward-looking statements as predictions of future or...